彩客新能源(01986.HK)擬增建年產能8萬噸磷酸鐵產品生產線
彩客新能源(01986.HK)公布,旗下山東彩客新材料年產能5萬噸的磷酸鐵產品生產線項目已完成建設,上月開始試生產並成功試運行,計及原有生產線,目前磷酸鐵產品年產能達8萬噸。
公司表示,為持續滿足下游鋰電池市場快速發展的需要,計劃於山東彩客新材料現有場地內進一步投資新建年產能8萬噸的磷酸鐵產品生產線,預計明年底前完成新建項目建設;同時又計劃於明年底前,將原有生產線產能由每年3萬噸擴建至6萬噸,令明年底前集團磷酸鐵產品總年產能可達到19萬噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.